Health ❯ Healthcare ❯ Obesity

Weight Loss

Medications GLP-1 Medications GLP-1 Drugs Pharmaceuticals Weight Loss Drugs Mounjaro Bariatric Surgery Weight Loss Injections Medication Semaglutide

Retatrutide Drives Unusually Large Weight Loss in People With Type 2 Diabetes

Regulators will now review whether the triple‑agonist’s large weight and blood‑sugar reductions translate into lasting health benefits.

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

GLP‑1 Drugs Appear to Raise Testosterone and Improve Sperm Measures in Obese Men

Severe GLP‑1 Overdoses Rise as Online Access and Compounded Vials Expand

Employers and Insurers Pull Back Coverage for GLP‑1 Weight‑Loss Drugs

Lilly’s Experimental Triple-Agonist Retatrutida Produces Weight Loss Comparable to Bariatric Surgery in Phase 3

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

India Braces for 50+ Semaglutide Generics as Patent Expires Friday

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

Ramadan Fasting: Doctors Urge Stable GLP-1 Use, Warn Against Starting or Raising Doses

GLP-1 Era Hits the Mainstream With Super Bowl Ads as Costs Rise and Care Shifts to Maintenance

Oxford BMJ Review Finds Rapid Weight Rebound After Stopping Modern Weight-Loss Drugs

Stopping Mounjaro Leads to Weight Regain and Reversed Health Gains, Study Finds

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Counterfeit ‘Ozempic’ Bought Online Puts Italian Woman in Coma, Prompting AIFA Investigation